LifePoint Health Inc (LPNT) : Ronald Blue Co scooped up 280 additional shares in LifePoint Health Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 10, 2016. The investment management firm now holds a total of 18,060 shares of LifePoint Health Inc which is valued at $1,046,577.LifePoint Health Inc makes up approximately 0.05% of Ronald Blue Co’s portfolio.
Other Hedge Funds, Including , Tower Research Capital (trc) added LPNT to its portfolio by purchasing 249 company shares during the most recent quarter which is valued at $14,430.Lbmc Investment Advisors reduced its stake in LPNT by selling 1,885 shares or 15.12% in the most recent quarter. The Hedge Fund company now holds 10,585 shares of LPNT which is valued at $617,529. LifePoint Health Inc makes up approx 0.12% of Lbmc Investment Advisors’s portfolio. Fuller Thaler Asset Management added LPNT to its portfolio by purchasing 1,700 company shares during the most recent quarter which is valued at $99,178.Louisiana State Employees Retirement System reduced its stake in LPNT by selling 500 shares or 4.17% in the most recent quarter. The Hedge Fund company now holds 11,500 shares of LPNT which is valued at $745,545. LifePoint Health Inc makes up approx 0.04% of Louisiana State Employees Retirement System’s portfolio.Weaver C. Barksdale Associates boosted its stake in LPNT in the latest quarter, The investment management firm added 32 additional shares and now holds a total of 362 shares of LifePoint Health Inc which is valued at $24,149. LifePoint Health Inc makes up approx 0.04% of Weaver C. Barksdale Associates’s portfolio.
LifePoint Health Inc opened for trading at $55.59 and hit $56.18 on the upside on Friday, eventually ending the session at $56.07, with a gain of 0.02% or 0.01 points. The heightened volatility saw the trading volume jump to 3,57,250 shares. Company has a market cap of $2,393 M.
On the company’s financial health, LifePoint Health Inc reported $0.71 EPS for the quarter, missing the analyst consensus estimate by $ -0.19 based on the information available during the earnings call on Jul 29, 2016. Analyst had a consensus of $0.90. The company had revenue of $1592.40 million for the quarter, compared to analysts expectations of $1607.66 million. The company’s revenue was up 25.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.
Many Wall Street Analysts have commented on LifePoint Health Inc. Shares were Reiterated by Mizuho on Aug 1, 2016 to “Neutral” and Lowered the Price Target to $ 56 from a previous price target of $61.50 .Shares were Reiterated by RBC Capital Mkts on Aug 1, 2016 to “Outperform” and Lowered the Price Target to $ 77 from a previous price target of $84 .
LifePoint Health Inc. formerly LifePoint Hospitals Inc. provides healthcare services. Through its subsidiaries the Company operates general acute care hospitals primarily in non-urban communities in the United States. Its hospitals provide a range of medical and surgical services in hospitals in non-urban markets. The Company’s services include general surgery internal medicine obstetrics emergency room care radiology oncology diagnostic care coronary care rehabilitation services and pediatric services. In some of its hospitals the Company offers services such as open-heart surgery skilled nursing psychiatric care and neuro-surgery. LifePoint provides outpatient services such as same-day surgery laboratory x-ray respiratory therapy imaging sports medicine and lithotripsy. The Company operates approximately 67 hospital campuses in 21 states having a total of approximately 8254 licensed beds.